Facebook
X
LinkedIn
ForwardPulse: Up in the Air: Optimizing Induction Immunosuppression Post-Lung Transplantation
There is limited evidence regarding the efficacy and safety of induction immunosuppression in lung transplantation. Additionally, there is no consensus regarding the superior agent. This presentation will investigate growing trends in induction immunosuppression strategies and seek opportunities to optimize choice of therapy.
Target Audience
Pharmacist
Learning Objectives
a. Describe the immunology, prevalence, and risk factors of acute cellular rejection in lung transplant recipients.
b. Discuss current evidence and trends regarding induction immunosuppressive therapy following lung transplantation.
c. Identify opportunities for optimization of induction immunosuppression based on clinical evidence and patient-specific factors.
Additional Information
| Attachment | Size |
|---|---|
 Audience Disclosure slide_37.pptx | 461.53 KB |
 Abstract_Georgiades.pdf | 49.12 KB |
There is limited evidence regarding the efficacy and safety of induction immunosuppression in lung transplantation. Additionally, there is no consensus regarding the superior agent. This presentation will investigate growing trends in induction immunosuppression strategies and seek opportunities to optimize choice of therapy.
Leah Georgiades, PharmD
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.